Total Payments
$2,608
2024 Payments
$152.67
Companies
19
Transactions
127
Medicare Patients
1,106
Medicare Billing
$118,147
Payment Breakdown by Category
Food & Beverage$1,986 (76.1%)
Travel$622.20 (23.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,986 | 124 | 76.1% |
| Travel and Lodging | $622.20 | 3 | 23.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $946.96 | 61 | $0 (2024) |
| Covidien LP | $745.77 | 6 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $160.89 | 14 | $0 (2021) |
| Janssen Biotech, Inc. | $105.62 | 8 | $0 (2021) |
| Ethicon Inc. | $103.07 | 1 | $0 (2018) |
| PFIZER INC. | $91.47 | 7 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $88.23 | 6 | $0 (2020) |
| IRONWOOD PHARMACEUTICALS, INC | $63.30 | 5 | $0 (2020) |
| Intercept Pharmaceuticals, Inc. | $61.84 | 2 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $43.87 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $152.67 | 11 | ABBVIE INC. ($152.67) |
| 2021 | $308.68 | 19 | AbbVie Inc. ($214.20) |
| 2020 | $262.73 | 18 | AbbVie Inc. ($140.66) |
| 2019 | $474.90 | 35 | AbbVie, Inc. ($222.04) |
| 2018 | $1,232 | 31 | Covidien LP ($745.77) |
| 2017 | $177.12 | 13 | AbbVie, Inc. ($47.58) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.39 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.45 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.51 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.57 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: IMMUNOLOGY | ||||||
| 09/01/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/18/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Immunology | ||||||
| 05/13/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $3.31 | General |
| Category: IMMUNOLOGY | ||||||
| 05/12/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: IMMUNOLOGY | ||||||
| 05/11/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: VIROLOGY | ||||||
| 05/04/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: IMMUNOLOGY | ||||||
| 05/04/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/29/2021 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $19.47 | General |
| Category: THERAPY FOR CSID | ||||||
| 04/15/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: IMMUNOLOGY | ||||||
| 04/07/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: IMMUNOLOGY | ||||||
| 03/23/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Immunology | ||||||
| 03/19/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/15/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 114 | 126 | $43,342 | $10,046 |
| 2022 | 5 | 225 | 236 | $114,993 | $20,981 |
| 2021 | 11 | 409 | 414 | $270,645 | $45,268 |
| 2020 | 10 | 358 | 363 | $124,951 | $41,853 |
Total Patients
1,106
Total Services
1,139
Medicare Billing
$118,147
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 52 | $19,871 | $5,139 | 25.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 42 | $8,082 | $2,555 | 31.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 21 | 21 | $5,133 | $1,341 | 26.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $10,256 | $1,011 | 9.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 86 | 89 | $27,452 | $7,005 | 25.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 26 | 26 | $33,734 | $4,914 | 14.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 40 | 40 | $31,766 | $3,545 | 11.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 53 | 61 | $13,042 | $3,406 | 26.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $8,999 | $2,112 | 23.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 58 | 58 | $75,780 | $11,332 | 15.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 98 | 99 | $61,355 | $7,457 | 12.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 39 | 40 | $53,855 | $6,705 | 12.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 76 | 77 | $14,269 | $5,782 | 40.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 33 | 34 | $31,078 | $3,495 | 11.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 25 | 25 | $8,807 | $3,140 | 35.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 25 | $5,734 | $2,391 | 41.7% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 15 | 15 | $8,275 | $1,935 | 23.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $2,817 | $1,287 | 45.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 19 | $3,342 | $968.42 | 29.0% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 11 | 11 | $5,334 | $775.05 | 14.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 115 | 117 | $41,301 | $10,752 | 26.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 34 | 34 | $21,624 | $7,102 | 32.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 58 | 58 | $8,468 | $4,692 | 55.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 35 | 35 | $8,925 | $4,252 | 47.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 35 | $8,390 | $3,695 | 44.0% |
About Dr. Rick Meyer, M.D
Dr. Rick Meyer, M.D is a Gastroenterology healthcare provider based in Troy, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700875747.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rick Meyer, M.D has received a total of $2,608 in payments from pharmaceutical and medical device companies, with $152.67 received in 2024. These payments were reported across 127 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,986).
As a Medicare-enrolled provider, Meyer has provided services to 1,106 Medicare beneficiaries, totaling 1,139 services with total Medicare billing of $118,147. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Troy, OH
- Active Since 10/20/2005
- Last Updated 06/04/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1700875747
Products in Payments
- Barrx (Device) $745.77
- Humira (Biological) $302.63
- HUMIRA (Biological) $284.88
- RINVOQ (Biological) $147.32
- STELARA (Biological) $110.24
- LINX Reflux Management System (Device) $103.07
- Entyvio (Biological) $101.73
- Mavyret (Drug) $95.20
- LINZESS (Drug) $77.19
- XIFAXAN (Drug) $73.86
- OCALIVA (Drug) $61.84
- XELJANZ (Drug) $53.50
- Creon (Drug) $41.60
- Linzess (Drug) $36.12
- Mulpleta (Drug) $32.44
- ZEPATIER (Drug) $31.94
- Cimzia (Drug) $30.35
- Amitiza (Drug) $29.80
- ENTYVIO (Biological) $29.36
- MOTOFEN (Drug) $24.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Troy
Dr. Partha Nandi, Md, MD
Gastroenterology — Payments: $242,021
Gastroenterology $242,021
Dr. Barry Pronold, M.d, M.D
Gastroenterology — Payments: $17,199
Gastroenterology $17,199
Dr. John Weber, Md, MD
Gastroenterology — Payments: $14,828
Gastroenterology $14,828
Dr. Mehmet Donat, Md, MD
Gastroenterology — Payments: $8,874
Gastroenterology $8,874
Dr. Robert Lamport, Md, MD
Gastroenterology — Payments: $7,628
Gastroenterology $7,628
Dr. Richard Wille, Md, MD
Gastroenterology — Payments: $4,855
Gastroenterology $4,855